CIK: 0001668029 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value ($000): $7,340 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ABG ACQUISITION CORP I | 501,300 | $4,978 | 67.8% | $9.89 | — | CL A SHS | G00496102 |
| — | APEXIGEN INC | 401,757 | $1,085 | 14.8% | $2.70 | — | COM | 03759B102 |
| — | SONENDO INC | 547,945 | $586 | 8.0% | $5.76 | — | COM | 835431107 |
| CSTL | CASTLE BIOSCIENCES INC | 20,592 | $537 | 7.3% | $23.24 | +20.6% | COM | 14843C105 |
| — | PRENETICS GLOBAL LTD | 25,000 | $95 | 1.3% | $4.04 | — | CLASS A ORD | G72245106 |
| — | AEGLEA BIOTHERAPEUTICS INC | 112,044 | $59 | 0.8% | $7.87 | — | COM | 00773J103 |